What does it actually take to extend healthy years, not just total years?

What's the difference between healthspan and lifespan?

Lifespan is total years lived. Healthspan is years lived with full function (cognitive sharpness, physical capability, energy, independence, and quality of life). For most people, lifespan exceeds healthspan by a meaningful margin: the last decade or so of life often involves significant decline.

Longevity medicine targets the gap. Extending lifespan without extending healthspan adds years of decline. Extending healthspan changes the years actually lived: more years of feeling well, being capable, and engaging fully with life. Most longevity-focused interventions that have strong evidence (exercise, sleep, metabolic health, cardiovascular risk reduction) extend both, but healthspan extension is the more meaningful target for most people.

What are the four healthspan domains?

Four domains determine quality of life as people age:

• Cardiovascular. Blood pressure, lipids (especially ApoB and Lp(a)), cardiovascular structure and function, vascular health
• Metabolic. Insulin sensitivity, glucose stability, body composition, liver function
• Cognitive. Memory, processing speed, executive function, mood, sleep architecture
• Physical function. Muscle mass and strength, balance, cardiorespiratory fitness, mobility, bone density

These aren't independent. Insulin resistance drives cardiovascular disease, and both drive cognitive decline. Cardiovascular health is brain health. Sarcopenia (the age-related loss of muscle mass) reduces physical function and increases fall risk, which can lead to head injury and brain trauma. Decline in any one of these domains pulls the others down with it.

The interventions that protect cognition are largely the same interventions that protect cardiovascular health, body composition, and physical capability. Optimizing one domain tends to support all four.

Why does standard preventive care miss so much?

Standard preventive screening is built for population averages, not for individual optimization. The recommended screenings catch disease that's already present or advanced. The advanced markers that catch risk decades earlier are typically not part of standard panels.

What standard screening covers: blood pressure, basic lipid panel, fasting glucose, age-appropriate cancer screening (colonoscopy, mammography, Pap smear, lung CT for high-risk smokers).

What's typically missing: ApoB and Lp(a) for cardiovascular risk, fasting insulin and HOMA-IR for early metabolic dysfunction, hs-CRP and homocysteine for inflammation, full thyroid panel including antibodies, comprehensive hormone assessment, advanced cancer screening, body composition, bone density, ApoE genotype for cognitive risk stratification.

The pattern: standard screening catches problems years after they could have been addressed, while precision medicine screening catches them when interventions have the largest effect.

What advanced markers actually matter?

The biomarkers that catch risk earlier and provide a clearer picture:

• Cardiovascular: ApoB (the actual count of atherogenic particles, more accurate than LDL-C alone), Lp(a) (a genetically-determined risk factor), advanced lipid panels with particle number and size, hs-CRP, homocysteine, coronary artery calcium (CAC) scoring
• Metabolic: Fasting insulin, HOMA-IR (a calculated insulin sensitivity score), comprehensive metabolic panel with liver enzymes (ALT often rises early in metabolic dysfunction)
• Cognitive: ApoE genotype, homocysteine, B12 with methylmalonic acid, comprehensive thyroid, omega-3 index, emerging blood tests for amyloid and p-tau
• Hormonal: Comprehensive panels appropriate to sex and age
• Inflammatory: hs-CRP, fibrinogen, ferritin (when interpreted as inflammatory marker), ESR
• Nutrient: Vitamin D, B12 with methylmalonic acid, RBC magnesium, omega-3 index, ferritin (the iron storage marker)

The 2024 National Lipid Association consensus endorsed ApoB as more accurate than LDL-C alone for cardiovascular risk assessment, with stratified targets: under 90 mg/dL for intermediate-risk, under 70 for high-risk, under 60 for very high-risk patients [PMID: 39256087]. Lp(a) screening is now strongly endorsed by major lipid societies for one-time lifetime measurement.

How does muscle factor into longevity?

Muscle isn't just for strength. It's metabolically active tissue that affects nearly every measure of healthspan:

• Muscle is the primary site of glucose disposal, so more muscle means better metabolic health
• Skeletal muscle produces myokines (signaling molecules) that regulate inflammation and metabolism throughout the body
• Sarcopenia (the age-related loss of muscle mass) is a stronger predictor of mortality and disability in older adults than body fat percentage [PMID: 25365952]
• Muscle and strength predict physical independence in aging
• Resistance training improves bone density, hormonal signaling, and cognitive function

Without intervention, the average adult loses approximately 8% of muscle mass per decade up to age 70, with steeper losses afterward. This decline is largely preventable through resistance training and adequate protein.

What interventions have the strongest evidence for extending healthspan?

The interventions consistently supported across study designs:

• Regular structured exercise. Combining aerobic training with resistance training. Among the most studied interventions, with consistent evidence for cardiovascular, metabolic, cognitive, musculoskeletal, and mortality benefits
• Adequate quality sleep, with appropriate architecture and treatment of sleep disorders
• Nutrient-dense whole-food eating patterns. Mediterranean and traditional dietary patterns have the most consistent evidence
• Maintaining metabolic health. Insulin sensitivity, glucose stability, body composition
• Treating cardiovascular risk factors aggressively. Blood pressure, ApoB, Lp(a) where applicable
• Maintaining lean muscle mass and bone density through resistance training and adequate protein
• Strong social connections and continued cognitive engagement
• Treating sleep apnea and hearing loss when present
• Managing inflammation through addressing upstream drivers
• Optimizing hormones where indicated

Newer pharmaceutical and supplement interventions exist with varying evidence. Distinguishing what's well-evidenced from what's still speculative is part of practicing longevity medicine responsibly.

The deeper picture

Longevity medicine is most effective when started before symptoms appear, ideally in the 30s, 40s, or 50s. A comprehensive baseline assessment maps the current state across all four healthspan domains and creates the framework for everything that follows. The compounding benefit of decades of optimized health is substantial. Extend works with patients on this kind of long-horizon prevention as part of standard care.